Skip to main content

Table 1 Patient characteristics (n = 47)a

From: MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity

 

n (%)

Age (median, range)

58 (34–77)

FIGO stage

 II

1 (2.1)

 IIIA

1 (2.1)

 IIIB

5 (10.6)

 IIIC

32 (68.2)

 IV

8 (17.0)

Residual disease

 None

16 (34.0)

 <2 cm

17 (36.2)

 >2 cm

13 (27.7)

Numbers of chemotherapy cycles

 <6

7 (14.9)

 6 or more

39 (83.0)

CSb

33 (70.2)

CRb

14 (29.8)

RFSc (mean/SE)

10.1 (1.4)

OSc (mean/SE)

41.4 (4.3)

  1. amissing clinicopathological information was assumed to be missing at random
  2. bCS chemosensitive, CR chemoresistant
  3. cRFS recurrence-free survival, OS overall survival